Should a pre-seed medtech company hire a fractional CRO in 2027?
Direct Answer
Medtech is a high-stakes, long-cycle industry. A fractional CRO can help you build a credible go-to-market strategy, identify early adopter segments, and set up the revenue operations stack before you have a product to sell. But at pre-seed, you likely don’t have enough revenue data or a repeatable sales motion for a full-time hire to be cost-effective. A fractional CRO gives you senior leadership without the full-time commitment, but you must be ready to act on their recommendations—otherwise, you’re paying for strategy that gathers dust.
Why Medtech Is Different from SaaS
Medtech sales cycles are longer, more regulated, and involve more stakeholders than typical B2B SaaS. You’re often selling to hospitals, clinics, or group purchasing organizations (GPOs) with compliance requirements, budget cycles, and clinical evidence demands. A fractional CRO with medtech experience understands these nuances—they know how to navigate FDA or CE marking timelines, talk to procurement officers, and position your product within a value-based care framework.
If your fractional CRO comes from a SaaS background without medtech exposure, they may push for rapid scaling tactics that don’t work in healthcare. You must vet for industry-specific knowledge, not just general sales leadership.
The Real Cost and Commitment
The cost of a fractional CRO at pre-seed is driven by three factors: scope of work, days per month, and equity versus cash split. A light engagement—say, 8–10 hours per week for strategy and monthly reviews—might run $5,000–$8,000 per month. A heavier engagement, where the CRO is actively building your sales process, training a junior hire, or managing early partnerships, can go to $12,000–$15,000 per month for 15–20 hours per week.
Equity is common but negotiable. Typical grants range from 0.5% to 2.0% with a 2–4 year vesting schedule and a one-year cliff. Some fractional CROs will accept a lower cash rate for higher equity if they believe in the company’s upside. Be transparent about your runway and cap table.
What You Actually Get
A good fractional CRO delivers four things at pre-seed:
- A go-to-market plan that identifies your ideal customer profile, pricing strategy, and channel approach (direct sales, distributor partnerships, or both).
- Revenue operations setup—CRM configuration (Salesforce or HubSpot), pipeline tracking, and basic reporting so you can measure what matters.
- Early customer introductions—they use their network to get you meetings with pilot sites, key opinion leaders, or potential channel partners.
- Hiring roadmap—they help you define when to hire your first full-time salesperson and what profile to look for.
They do not magically generate revenue if your product isn’t ready. They cannot fix a broken value proposition or a lack of clinical evidence. Set realistic expectations: the goal is to build a foundation, not hit a revenue number in month one.
When to Say No
Fractional CRO is not the right move if:
- You have no prototype or MVP. You need something to show, even if it’s a wireframe or bench-top model. Otherwise, you’re paying for market research you could do yourself.
- Your runway is under 6 months. The CRO’s fees will eat into cash you need for development. Consider a deferred-equity arrangement or wait until you raise a seed round.
- You’re not ready to act on feedback. If you ignore pricing recommendations or refuse to cold-call potential pilots, the engagement will fail. You must be coachable.
- You need a full-time closer. If you already have a proven sales process and just need someone to execute, hire a full-time VP of Sales or a sales development rep. Fractional is for building, not scaling.
How to Find the Right Fractional CRO
Medtech fractional CROs are rare. Most fractional revenue leaders come from SaaS, fintech, or professional services. Look for specific medtech signals:
- Previous roles at medical device, diagnostics, or digital health companies.
- Experience with hospital procurement, GPOs, or regulatory submissions.
- A network of clinical contacts or distributor relationships.
FAQ
What is the minimum engagement length for a fractional CRO? Most fractional CROs require a 3-month minimum commitment, with a 30-day notice for termination. Some will do month-to-month after the initial period. Be clear about this in your contract.
Can a fractional CRO work remotely for a medtech company? Yes. Strong fractional CROs often work remote or hybrid, especially if local medtech talent is thin. They should be willing to travel for key customer meetings or board presentations a few times per quarter.
How do I measure success for a fractional CRO at pre-seed? Focus on leading indicators: number of qualified pilot conversations, CRM hygiene, clarity of pricing model, and progress toward first revenue. Do not expect a specific ARR number in the first 6 months.
Will a fractional CRO take equity instead of cash? Some will accept a mix, especially if they believe in the company. Expect to offer 0.5–2.0% equity with a 4-year vesting schedule and a one-year cliff. Cash is still required for most engagements.
What happens if the fractional CRO doesn’t deliver? Have a written scope of work with clear deliverables and a mutual opt-out clause. Regular check-ins (weekly or biweekly) help catch issues early. If it’s not working, end the engagement professionally and move on.
Should I hire a fractional CRO or a full-time VP of Sales first? At pre-seed, fractional is almost always the better choice. You don’t have enough revenue data or a repeatable process to justify a full-time VP. Use the fractional CRO to build the foundation, then hire full-time when you raise a seed or Series A.
Sources
People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost